Targeting an epigenetic silencing pathway to treat allergic asthma [ 2017 - ]

Research Grant

Researchers: Dr Christine Keenan (Principal investigator)

Brief description Asthma affects around 11% of the Australian population and costs the health care system around $28 billion. Unfortunately there is still no cure and treatments have not changed for decades. This project aims to discover new drugs to treat asthma by re-wiring the cells of the immune system which cause the disease.

Funding Amount $318,768.00

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF